Product Usage
This product is intended for research purposes only. All product information available on this website is for educational purposes only. This product is not intended for consumption or bodily introduction of any kind. It should only be handled by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
PT-141
PURITY ≥99%/LOT LL-0824/HPLC VERIFIED
Select Your Dosage
PT-141 — MC3R/MC4R Selective Agonist. 5 mg / 10 mg.
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Not intended for consumption of any kind.
03 / Research Context
Research context
PT-141 is a cyclic heptapeptide functioning as a selective agonist at MC3R and MC4R. It acts centrally within neurological melanocortin pathways to modulate specific behavioral and autonomic responses.
Key research areas
- FDA-approved for HSDD (as Vyleesi)
- Acts centrally in brain — not on blood flow
- Activates sexual desire through MC3R/MC4R
- Effective in both male and female models
- Onset 30-60 minutes, effects last 6-72 hours
- Unique melanocortin mechanism of action
Handling & reconstitution
Supplied as a lyophilized powder. Bacteriostatic water is the recommended solvent for reconstitution in research applications. Store unreconstituted product at -20°C; reconstituted solutions should be stored at 2-8°C and used within 14–30 days.
Research use only. Not for human consumption.
Product specifications
| Type | MC3R/MC4R Selective Agonist |
| Composition | 5 mg / 10 mg |
| Amino Acids | 7 (cyclic) |
| Purity | 99%+ |
| Appearance | Lyophilized Powder |
| Storage | 2-8°C |
